We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Jazz Pharmaceuticals Garners FDA Approval for Rare Liver Disease Drug
Jazz Pharmaceuticals Garners FDA Approval for Rare Liver Disease Drug
Dublin, Ireland-based Jazz Pharmaceuticals has scooped up FDA approval for its hepatic veno-occlusive disease treatment Defitelio, the first approved therapy to treat the rare and life-threatening liver condition.